Purchase Order HHSN271201700160P

Award Date 2/14/17
Potential Completion Date 3/30/17
Potential Value $126K
Funding Federal Agency
National Institute on Drug Abuse
Awardee
Edelris
Ultimate Awardee
Not listed
PSC Category
6810 - Chemicals
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
France
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $90,000.00 firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), which is a civilian agency of the U.S. government. The contract, which does not have a set-aside designation, is for the "SMALL MOLECULES FOR NCATS PHARMACOLOGICALLY ACTIVE CHEMICAL TOOLBOX (NPACT)" program and was awarded to DC Chemicals LIMITED, a for-profit limited liability company, on July 9, 2015. The period of performance for this contract ends on November 30, 2015.
<p>The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a firm-fixed-price purchase order to Chemdiv, Inc. to provide 10,000 proprietary chemical compounds at 8 micromolar each. The total potential value of the award is $128,000.00. The award was not set aside for any specific business type. The contract has a completion date of September 4, 2017.</p>
<p>This is a firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Biovision Inc., a small disadvantaged business, on April 24, 2015. The contract is for the Small Molecules for NCATS Pharmacologically Active Chemical Toolbox (NPACT) program, with a ceiling value of $95,640.25 and a completion date of July 25, 2015. The contract does not have a set-aside designation.</p>
This federal contract award, identified as 75N95018P00712, was made by the National Institute on Drug Abuse (NIDA), a civilian agency, to Molport SIA, a for-profit limited liability company located in Latvia. The contract, valued at $51,771.73, is for the purchase of a Chemical Library of 216 small molecule compounds. The contract is a firm fixed-price purchase order with an ultimate completion date of January 31, 2019. The contract was awarded on September 20, 2018, following a pre-solicitation...
<p>This is a $18,963.00 firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to NINDS PHARMAC LLC for medicinal chemistry consulting services. The contract has a Total Small Business set-aside designation. The contract was awarded on January 12, 2017 and has an ultimate completion date of January 12, 2022. The place of performance is Bethesda, Maryland.</p>
This is a $80,400.00 firm fixed price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Axon Medchem B.V., a foreign-owned for-profit organization. The contract is for the Small Molecules for NCATS Pharmacologically Active Chemical Toolbox (NPACT) program, which aims to provide small molecule compounds. The contract has an ultimate completion date of July 25, 2015 and was awarded on April 24, 2015. There was no set-aside designation used for...
This is a $150,000.00 firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse, a civilian agency, to Edythe A. Wiggs, a for-profit woman-owned business. The contract has a period of performance through February 21, 2020 and was awarded on February 22, 2017. This contract does not appear to be associated with a larger contract vehicle and has no set-aside designation. The contract is for services or products related to the mission and programs of the National...
<p>This is a $460,000.00 firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Charles River Discovery Research Services UK LIMITED, a foreign-owned for-profit organization. The contract is for the Small Molecules for NCATS Pharmacologically Active Chemical Toolbox (NPACT) program, with a performance period ending on January 31, 2016. The contract does not have a set-aside designation.</p>
<p>The U.S. National Institute on Drug Abuse (NIDA), a civilian agency, awarded a $87,672.00 Firm Fixed Price Purchase Order contract to Glixx Laboratories, Inc., a self-certified small disadvantaged business. The contract is part of the Small Molecules for NCATS Pharmacologically Active Chemical Toolbox (NPACT) program, and has an ultimate completion date of November 30, 2015. The contract does not have a set-aside designation.</p>
This is a $112,329.81 firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Maris Solutions LLC, a self-certified small disadvantaged business, woman-owned small business. The contract does not have a set-aside designation and the ultimate completion date is August 31, 2016. The contract is for unspecified products or services, as the original solicitation was not provided. There is no indication of any major subcontractors or that...

This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Edelris, a for-profit manufacturer, for the delivery of 5,050 proprietary chemical compounds at 1 milligram and 2 x 1 milligram each. The total ceiling value of the contract is $126,150.00, and the ultimate completion date is March 30, 2017. The contract does not have a set-aside designation.

Generated 4/2/25, 7:27 PM